NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells
NCT02892292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2016-09-08
Summary
The objective of this study is to realize the typing of all HLA loci and validate this technique with continued optimization of next-generation sequencing technology (NGS).
Conditions
- Next Generation Sequencing for HLA Typing
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Principal Investigators
-
Virginie Moalic-Allain, Doctor · CHRU de Brest
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- France
Study Locations
More Related Trials
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers
NCT02940093 ·Status: UNKNOWN
-
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
NCT07297303 ·Status: RECRUITING
-
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
NCT00179049 ·Status: COMPLETED
-
Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut
NCT07305090 ·Status: RECRUITING
-
Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)
NCT02194868 ·Status: COMPLETED
-
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
NCT02450708 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells
NCT06798298 ·Status: RECRUITING
-
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
NCT06856226 ·Status: RECRUITING
-
Home Transfusion for HEME
NCT05509439 ·Status: COMPLETED ·Phase: NA
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Graft-versus-host Disease Associated Myelosuppression
NCT02829216 ·Status: UNKNOWN
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523 ·Status: COMPLETED
-
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00504803 ·Status: COMPLETED ·Phase: PHASE2
-
Toward Immune Biomarkers for Tolerance and GvHD in Humans
NCT02319226 ·Status: UNKNOWN
-
A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant
NCT04494061 ·Status: TERMINATED
-
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT05866302 ·Status: RECRUITING
-
Immunoglobulin Gene Rearrangement and Repair in Healthy Donors
NCT04889573 ·Status: COMPLETED ·Phase: NA
-
Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease
NCT00723593 ·Status: WITHDRAWN
-
Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.
NCT06208137 ·Status: RECRUITING ·Phase: NA
-
Investigating Cytokine Genes of Stem Cell Donors
NCT00353821 ·Status: COMPLETED
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft
NCT03280290 ·Status: COMPLETED ·Phase: NA